 Hello, everybody, and welcome to day two of the Genomic Medicine 13 meeting. We had a really productive day one, a lot of input and interactivity despite the virtual formats, so we're hoping that that will continue today. Let me just provide a little bit of orientation for how day two will work. We will have two sessions that are going to be very similar to the sessions that we had on day one with different areas of content focus. We're then going to be taking a longer break, approximately one hour towards the end of the day today. That will allow my coach here, Ken Wiley, and myself to synthesize our takeaways from day two and merge them with some work that we've already put in for takeaways for day one. Then we'll reconvene the meeting for an open discussion where we'll walk through the takeaways to make sure that we captured the information accurately, and also to make sure that we did not miss anything that was important. This session is going to be really critical for our next steps, which will be to create a meeting summary, but also to develop a publication that will let a wider audience know what we have been trying to accomplish. Of course, the major takeaway will be for this meeting to inform work within the NHGRI about developing a research strategy, research portfolio around clinical informatics and genomics. This will hopefully result in the next few months in some information from NHGRI about how we're going to move this forward. With that as the prelude, first of all, I want to begin by thanking all of the presenters yesterday for being very attentive to time limits. We hope that that will continue today. We want to thank all the co-moderators for the excellent job that you've been doing in terms of moderating the discussions after the presentations. A reminder that you can contribute questions either through the question and answer box, through the chat function or verbally by letting the co-moderators know that you have something to contribute. All of those will be captured. A reminder that we are recording the session, so all of this will be recorded and will be ultimately available on the genomic medicine meeting site where all of the prior meetings reside as durable materials. These are happening long enough now that some of us who have been involved from the first meeting are beginning to recognize changes in appearance over the course of the years that have taken place, and unfortunately, it's not a Dorian Gray experience for most of us. In any case, let's go ahead and launch into session four, defining a research agenda that addresses the process for developing genomic-based clinical informatics resources. This session will be co-moderated by Dr. Aaron Krauge, who is the director of medical bioinformatics at Namors-Dupont Hospital for Children, and is also the director of management of the Delaware A-Cell, which is the Accelerating Clinical and Translational Research for Delaware. Dr. Krauge has a broad research portfolio with the goal of implementing a learning healthcare system to enhance precision medicine. Our second co-moderator for this session is Dr. Dan Rodin. Dan is a member of the Genomic Medicine Working Group, has been from the inception of this group. He has a very long history of research in genomics and personalized and precision medicine, and has led programs such as the Vanderbilt BioView Program, the Predict Pharmacogenetics Program, and has been PIN projects through the Pharmacogenomics Research Network, the Electronic Medical Records and Genomics from Phase 1 through Phase 4, and has a co-PI of the All of Us data and research center that's housed at Vanderbilt. So with that, I will turn it over to Dr. Krauge and Rodin.